Gastric cancers were divided into MSI and microsatellite stable (MSS) with MSS tumors further divided into MSS/EMT and MSS/TP53+ and MSS/TP53− subtypes representing epithelial–mesenchymal transited, activation or inactivation of the TP53 pathway, respectively. The gene discussed is TP53; the disease is gastric cancer.